Effect of Smac on TRAIL-induced apoptosis of prostate cancer cell line PC-3 and the molecular mechanism

Abstract

The effect of Smac gene on the TRAIL-induced apoptosis of the prostate cancer cell line PC-3 and the molecular mechanism were investigated. The Smac gene was transfected into PC-3 cells under the induction of liposome. The intrinsic Smac gene expression was detected by Western blotting. After treatment with TRAIL as an apoptosis inducer, in vitro cell growth activity was assayed by MTT colorimetry. The apoptosis rate of PC-3 cells was determined by annexin V-FITC and propidium iodide staining flow cytometry. The expression of cellular XIAP and caspase-3 genes was examined by Western blotting. Smac-transfected cells (PC-3/Smac group) had significantly increased Smac protein level as compared with PC-3 controls (P<0.01). After induction with 100–200 ng/mL TRAIL for 12–36 h, cellular proliferation rate in PC-3/Smac group was significantly lower than in PC-3 controls (P<0.05). After induction with 100 ng/mL TRAIL for 24 h, the apoptosis rate in PC-3/Smac group was significantly enhanced as compared with that of PC-3 controls (P<0.05). Accordingly, the XIAP expression level was down-regulated significantly (P<0.05) and caspase-3 subunit P20 was up-regulated significantly (P<0.05). It is suggested that the over-expression of cellular Smac can inhibit inhibitor of apoptosis proteins (IAPs), enhance caspases activity and the apoptosis rate of PC-3 cells induced by TRAIL, which may provide a useful experimental basis for prostate cancer therapy.

Keywords

Smac gene / prostate carcinoma / TRAIL / apoptosis

References

[1] NilssonS., RagnhammarP., GlimeliusB., et al.. A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol, 2001, 40(2–3): 371-390

[2] LiuJ., WangQ., WangX., et al.. Apoptosis of bladder cancer cells induced by short-term and low-dose Mitomycin-C: potential molecular mechanism and clinical implication. Int J Mol Med, 2003, 11(3): 389-394

[3] ZhengL.D., TongQ.S., WangL., et al.. Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells. World J Gastroenterol, 2005, 11(1): 79-83

[4] McNeishI.A., BellS., McKayT., et al.. Expression of Smac/DIABLO in ovarian carcinoma cells induces apoptosis via a caspase-9-mediated pathway. Exp Cell Res, 2003, 286(2): 186-198

[5] JiaL., PatwariY., KelseyS.M., et al.. Role of Smac in human leukaemic cell apoptosis and proliferation. Oncogene, 2003, 22(11): 1589-1599

[6] ConradtB.. Genetic control of programmed cell death during animal development. Annu Rev Genet, 2009, 43: 493-523

[7] ThompsonC. B.. Apoptosis in the pathogenesis and treatment of disease. Science, 1995, 267(5203): 1456-1462

[8] SalvesenG.S., DixitV.M.. Caspases: intracellular signaling by proteolysis. Cell, 1997, 91(4): 443-446

[9] FriedrichK., WiederT., Von HaefenC., et al.. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene, 2001, 20(22): 2749-2760

[10] MartinS.J.. Destabilizing influences in apoptosis: sowing the seeds of IAP destruction. Cell, 2002, 109(7): 793-796

[11] HuangY., ParkY.C., RichR.L., et al.. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell, 2001, 104(5): 781-790

[12] KevinR., McElenyR., WilliamG., et al.. Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate, 2002, 51(2): 133-140

[13] AshkenaziA., PaiR.C., FongS., et al.. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 1999, 104(2): 155-162

[14] JoM., KimT.H., SeolD.W., et al.. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med, 2000, 6(5): 564-567

[15] RayS., AlmasanA.. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor 2-related apoptosis-inducing ligand and CPT211. Cancer Res, 2003, 63(15): 4713-4723

[16] WangC.X., YouleR.J.. The Role of mitochondria in apoptosis. Annu Rev Genet, 2009, 43: 95-118

[17] DuC., FangM., LiY., et al.. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 2000, 102(1): 33-42

[18] VerhagenA.M., EkertP.G., PakuschM., et al.. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 2000, 102(1): 43-53

[19] AdrainC., CreaghE.M., MartinS.J.. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J, 2001, 20(23): 6627-6636

[20] FuldaS., WickW., WellerM., et al.. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nature Med, 2002, 8(8): 808-815

[21] ChristinaR.A., MihneaV.C., MichaelP.H., et al.. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J Biol Chem, 2002, 277(46): 44236-44243

[22] TammI., KornblauS.M., SegallH., et al.. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res, 2000, 6(5): 1796-1803